Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-fluorothymidine Positron Emission Tomography
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Brain Tumor
Both
Brain Tumor
Trial Information
Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-fluorothymidine Positron Emission Tomography
In this study, 35 patients will be selected to undergoing sequential imaging with FLT-PET.
Prior to surgical resection, patients will undergo a preliminary FLT-PET. Additional FLT
scans for a maximum of four scans.
Inclusion Criteria:
- 18 years or older
- Women must not be pregnant or breast feeding
- Histologic or strong radiologic suspicion of high grade malignant glioma or
ogliometastatic tumor(s)
Exclusion Criteria:
- May not have received previous therapy for their malignancy
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Principal Investigator
Jennifer Holter, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Assistant Professor
Authority:
United States: Food and Drug Administration
Study ID:
FLT- Brain Study
NCT ID:
NCT00775320
Start Date:
October 2008
Completion Date:
Related Keywords:
- Brain Tumor
- Brain scan
- Brain Neoplasms
Name | Location |
|---|---|
| University of Oklahoma Health Sciences Center | Oklahoma City, Oklahoma 73104 |
